Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-19 Sale | 2023-12-21 4:01 pm | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 100,000 | $59.17 | $5,917,368 | 520,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-01 Disposition | 2023-10-03 7:30 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 62,972 | $0 | 303,227 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:30 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 64,844 | $0 | 303,227 (Direct) | View |
| 2023-04-05 Disposition | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 557,931 | $0 | 368,071 (Direct) | View |
| 2023-04-05 Conversion | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 574,517 | $0 | 368,071 (Direct) | View |
Ownership | 2022-04-15 4:06 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 0 | $0 | 942,588 (Direct) | View |